Biopharmaceutical Market By Source & By Products 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biopharmaceutical market
Biopharmaceutical Market: By Source (Unicellular & Multicellular Systems) By Products (Vaccines, Enzymes, Others) Manufacturing Process (Single & Multi Use Systems) Application (Oncology, Cardiology, Others) End Users (Hospitals, Others)-Forecast(2015-2020)
Report Code : HCR 0054
Published: 19 August, 2015   No. of pages: 78

  • Report Description
  • Table of Contents
  • Customization Options
Biopharmaceuticals are large and complex products isolated from genetically modified living organisms. Recently, biologics or biopharmaceuticals is one of the fastest growing sectors of pharmaceutical industries, owing to its innovative nature, greater safety and efficacy compared to traditional drugs.

The market for Biopharmaceutical is classified into three categories based on source, type of products and application areas, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biopharmaceuticals market.

The overall Biopharmaceutical Market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2015 are detailed.

The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.

The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biopharmaceuticals market and future opportunities that can propel the market.

The report contains the most detailed and in-depth segmentation and analysis of the Global Biopharmaceuticals Market during the forecast period 2015 - 2020.
1. Global Biopharmaceutical Market Overview
2. Executive Summary
3. Global Biopharmaceutical Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. Patent Analysis
      3.2.3. End user profiling
      3.2.4. Top 5 Financials Analysis
4. Biopharmaceutical Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Biopharmaceutical Market Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product lifecycle
   5.4. Pricing Analysis
6. Biopharmaceutical Market- By Source
   6.1. Unicellular System
      6.1.1. Bacteria
      6.1.2. Yeast
      6.1.3. Insect
   6.2. Multicellular System
      6.2.1. Transgenic Plant
      6.2.2. Transgenic Animal
7. Biopharmaceutical Market- By Products
   7.1. Vaccines
   7.2. Hormones
   7.3. Enzymes
   7.4. Blood
   7.5. Blood Components
   7.6. Monoclonal Antibodies
   7.7. Growth Factors
   7.8. Gene Therapies
   7.9. Thrombolytics and Anticoagulants
   7.10. Recombinant Therapeutic Protein
8. Biopharmaceutical Market- By Manufacturing Process
   8.1. Single-Use System
   8.2. Multi- Use System
9. Biopharmaceutical Market- By Application
   9.1. Rheumatology
   9.2. Oncology
   9.3. Cardiology
   9.4. Dermatology
   9.5. Gastroenterology
   9.6. Neurology
   9.7. Others
10. Biopharmaceutical Market- By End Users
   10.1. Biopharmaceutical Companies
   10.2. Hospitals
   10.3. Research Institutes
   10.4. CROs
   10.5. Diagnostic Labs
11. Biopharmaceutical Market -Geographic Analysis
   11.1. North America
      11.1.1. Canada
      11.1.2. Mexico
      11.1.3. USA
      11.1.4. Others
   11.2. Europe
      11.2.1. France
      11.2.2. Germany
      11.2.3. Italy
      11.2.4. Sweden
      11.2.5. U.K
      11.2.6. Others
   11.3. APAC
      11.3.1. China
      11.3.2. India
      11.3.3. Japan
      11.3.4. Australia
      11.3.5. Others
   11.4. ROW
      11.4.1. South Africa
      11.4.2. South America
      11.4.3. Russia
      11.4.4. Saudi Arabia
      11.4.5. Others
12.  Biopharmaceutical Market Entropy
   12.1. New Product Launches
   12.2. M&As, Collaborations, JVs and Partnerships
13.  Company profiles
   13.1. Johnson & Johnson Private Limited
   13.2. Roche Holding AG
   13.3. Abbott Laboratories
   13.4. Bristol-Myers Squibb
   13.5. Novartis International AG
   13.6. Genentech Inc.
   13.7. UCB
   13.8. Merck Serono
   13.9. Amgen
   13.10. Eli Lilly & Co.
   13.11. Biogen Idec
   13.12. Merck KGaA
   13.13. √Član Corporation
   13.14. BioMarin Pharmaceutical Inc.
   13.15. AbbVie Inc.
   13.16. Invion Limited
   13.17. AdAlta Pty Ltd.
   13.18. Admedus Ltd
   13.19. Biota Pharmaceuticals Inc.
   13.20. Novozymes
   13.21. Baxter International
   13.22. APEIRON Biologics AG
   13.23. Octapharma AG
   13.24. Valneva SE
   13.25. Genzyme
   13.26. Mallinckrodt Pharmaceuticals
   13.27. TM3 Therapeutics
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14.  Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
   14.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports